Cellectar Biosciences, Inc. (CLRB) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.85M | -4.34M | -4.28M | -5.12M | -9.38M | -10.91M | -9.17M | -14.14M | -13.36M | -9.6M | -8.07M | -7.53M | -7.18M | -7.41M | -7.01M | -5.76M | -5.04M | -4.51M | -6.43M | -6.88M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 48.36% | 60.19% | 53.36% | 63.82% | 29.77% | -13.73% | -13.62% | -87.8% | -86% | -29.47% | -15.04% | -30.78% | -42.54% | -64.3% | -9.09% | 16.27% | -6.04% | -16.6% | -83.58% | -125.46% |
| Net Income | -5.65M | -5.3M | -4.44M | -5.45M | -6.6M | -2.36M | -14.66M | -919.37K | -26.64M | -7.88M | -17.52M | -10.18M | -7.19M | -7.22M | -7.81M | -7.44M | -6.14M | -5.92M | -5.82M | -6.03M |
| Depreciation & Amortization | -110.02K | 49.46K | 52.28K | 55.56K | 56.3K | 68.57K | 68.57K | 66.02K | 88.49K | 69.96K | 41.21K | 38.65K | 42.56K | 38.16K | 32.96K | 33.9K | 43.42K | 39.29K | 36.79K | 38.7K |
| Stock-Based Compensation | 0 | 0 | 0 | 565.39K | 562.74K | 1.49M | 1.53M | 0 | 454.36K | 0 | 497.88K | 419.76K | 408.21K | 361.45K | 367.76K | 419.95K | 303.81K | 377.85K | 421.16K | 200.62K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 371.62K | 290.12K | 292.92K | -464.97K | 340K | -10.05M | 1.67M | -11.64M | 14.96M | -3.37M | 8.17M | 1.99M | -1.39M | 23.89K | 23.01K | 25.56K | 21.36K | 20.56K | 19.79K | 19.05K |
| Working Capital Changes | 546.78K | 611.5K | -176.44K | 176.4K | -3.74M | -63.56K | 2.22M | -1.65M | -2.22M | 1.58M | 740.64K | 205.06K | 946.83K | -620.16K | 374.41K | 1.2M | 731.43K | 969.39K | -1.09M | -1.11M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 301.28K | 408.87K | -664.03K | 0 | 0 | 0 | 0 | -930.74K | 0 | 1.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -3.38K | -5.88K | 0 | 0 | 0 | -61.29K | 0 | -21.28K | -21.63K | -266.76K | -597.28K | 0 | 0 | -117.86K | -7.07K | -70.98K | -30.07K | -129.74K | -4.06K | -7.56K |
| Capital Expenditures | -3.38K | -5.88K | 0 | 61.29K | 0 | -61.29K | 0 | -21.28K | -21.63K | -266.76K | -597.28K | 0 | 0 | -117.86K | -7.07K | -70.98K | -30.07K | -129.74K | -4.06K | -7.56K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -61.29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 4.99M | 5.79M | 2.25M | 0 | 0 | 17.56M | 1 | 43.85M | 441K | 22.5M | 0 | 3 | 9.61M | 0 | 0 | 0 | -1 | 0 | 34.87K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 4.99M | 5.79M | 2.25M | 0 | 0 | 0 | 1 | 0 | 441K | 0 | 0 | 0 | 9.61M | 0 | 0 | 0 | -1 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 17.56M | 0 | 43.85M | 0 | 22.5M | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 34.87K |
| Net Change in Cash | -4.85M | 641.74K | 1.51M | -2.86M | -9.38M | -10.97M | 8.39M | -14.16M | 30.47M | -9.42M | 13.83M | -7.53M | -7.18M | 2.08M | -7.02M | -5.83M | -5.07M | -4.64M | -6.43M | -6.85M |
| Free Cash Flow | -4.85M | -4.35M | -4.28M | -5.12M | -9.38M | -10.97M | -9.17M | -14.16M | -13.38M | -9.86M | -8.67M | -7.53M | -7.18M | -7.53M | -7.02M | -5.83M | -5.07M | -4.64M | -6.43M | -6.88M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 48.32% | 60.36% | 53.36% | 63.88% | 29.89% | -11.28% | -5.79% | -88.09% | -86.3% | -30.98% | -23.43% | -29.19% | -41.69% | -62.25% | -9.13% | 15.33% | -6.68% | -19.42% | -83.7% | -123.17% |
| FCF per Share | -1.14 | -1.03 | -1.35 | -3.18 | -6.11 | -7.85 | -6.99 | -11.35 | -13.68 | -15.23 | -22.99 | -20.06 | -19.14 | -24.27 | -34.47 | -28.62 | -24.89 | -22.79 | -32.24 | -39.14 |
| FCF Conversion (FCF/Net Income) | 0.86x | 0.82x | 0.96x | 0.94x | 1.42x | 4.63x | 0.63x | 15.38x | 0.50x | 1.22x | 0.46x | 0.74x | 1.00x | 0.60x | 0.90x | 0.77x | 0.82x | 0.76x | 1.10x | 1.14x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |